ALLARTA

Serial Number 99042716
641

Registration Progress

Application Filed
Feb 18, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Oct 24, 2025 85 days

Trademark Image

ALLARTA

Basic Information

Serial Number
99042716
Filing Date
February 18, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Jul 24, 2025
Application
Pending
Classes
001 005 010 042

Rights Holder

Allarta Life Science Inc.

03
Address
36 Cayley St
Dundas, ON L9H 2E7

Ownership History

Allarta Life Science Inc.

Original Applicant
03
Dundas, ON

Legal Representation

Attorney
Brian Chau

USPTO Deadlines

Next Deadline
85 days remaining
Non-Final Action Mailed
Due Date
October 24, 2025
Extension Available
Until January 24, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

7 events
Date Code Type Description Documents
Jul 24, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 24, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 23, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 9, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 18, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 18, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemical agents for scientific and medical research use, namely, macromolecules for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants, for use in the research, discovery and development of implantable medical devices and cell therapies; chemical agents for coating of implantable medical devices and for encapsulating pharmaceutical agents and cells for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants.
Class 005
Pharmaceutical preparations for the treatment of endocrine diseases and oncological diseases; stem cells for medical purposes; stem cells and progenitor cells for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system; stem cells and progenitor cells for use in the production of biologic substances, namely, growth factors and proteins for medical purposes; Hormone replacement therapy preparations; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for use in immunomodulation therapies; surgical implants comprised of living tissues; surgical implants grown from stem cells
Class 010
Implants including artificial materials for medical use and diagnostic use; coatings sold as an integral component of implantable medical devices, namely, polymers and chemical compounds
Class 042
Research and development of immune system treatments; Medical and scientific research in the field of stem cell therapy and cell transplantation therapies; Medical research; biopharmaceutical development, research and evaluation of stem cell-based therapeutics for the treatment of diseases and disorders; production of therapeutical cellular products, active ingredients production for cell based therapies; medical treatment using cultured cells; stem cell therapy services

Classification

International Classes
001 005 010 042